15 July 2013
Rhabdomyosarcoma of the breast – a rare malignancy
Suresh J. BhosaleA, Ashok Y. KshirsagarE, Soniya R. SulhyanF, Sanjitsingh R. SulhyanBDOI: 10.12659/AJCR.883976
Am J Case Rep 2013; 14:250-252
Abstract
Background: Primary nonepithelial malignancies of the breast include primary breast sarcomas, therapy-related breast sarcomas, the phyllodes tumors, and primary breast lymphomas. They account for less than 5% of all breast neoplasms.
Case Report: We report the case of a 60-year-old postmenopausal female diagnosed with rhabdomyosarcoma with infiltrating duct carcinoma. She was treated with modified radical mastectomy with axillary clearance and postoperative chemotherapy.
Conclusions: Primary rhabdomyosarcoma of the breast in adults is extremely rare. Rhabdomyosarcomas in adults account for less than 3% of all adult primary soft-tissue sarcomas.
Primary breast sarcomas usually present as large painless breast lumps with no associated skin and nipple changes or axillary lymphadenopathy; they are more aggressive and have more rapid growth than epithelial malignancies or benign breast lesions. The tumor can grow to large size, around 5.8 cm. Affected patients are typically women in their 50 s (ranging from 17 to 89 years), but it is also seen in men.
The treatment of primary breast sarcomas requires a multidisciplinary approach. Surgery remains the mainstay of therapy. Chemotherapy has no clearly defined role in primary breast or soft-tissue sarcomas.
The prognosis of primary breast sarcomas depends on the histologic grade and size of the tumor. They spread locally and hematogenously, but they are not usually associated with axillary lymphadenopathy.
Keywords: Rhabdomyosarcoma, Breast, Rhabdomyosarcoma breast
602 2
In Press
28 Sep 2023 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.940411
28 Sep 2023 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.939789
27 Sep 2023 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.941414
26 Sep 2023 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.940966
Most Viewed Current Articles
06 Dec 2021 : Case report
DOI :10.12659/AJCR.934406
Am J Case Rep 2021; 22:e934406
07 Dec 2021 : Case report
DOI :10.12659/AJCR.934347
Am J Case Rep 2021; 22:e934347
13 Jul 2022 : Case report
DOI :10.12659/AJCR.936441
Am J Case Rep 2022; 23:e936441
23 Feb 2022 : Case report
DOI :10.12659/AJCR.935250
Am J Case Rep 2022; 23:e935250